These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 4672297

  • 1. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
    Del Pozo E, Del Re RB, Varga L, Friesen H.
    J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297
    [No Abstract] [Full Text] [Related]

  • 2. [Inhibition of lactation with 2 Br-alpha-ergocryptine].
    Jaszmann L, Szabó E, Szontágh F.
    Orv Hetil; 1974 Sep 01; 115(35):2053-4. PubMed ID: 4603634
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proceedings: Effects of inhibition of prolactin secretion by 2-Br-alpha-ergocryptine at parturition and during lactation in dairy cows.
    Fell LR, Chandler NJ, Goding JR.
    J Reprod Fertil; 1974 Feb 01; 36(2):480-1. PubMed ID: 4819349
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
    Floss HG, Cassady JM, Robbers JE.
    J Pharm Sci; 1973 May 01; 62(5):699-715. PubMed ID: 4574586
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R, Nagasawa H.
    J Natl Cancer Inst; 1970 Dec 01; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract] [Full Text] [Related]

  • 13. Two-bromo- -ergocryptine (CB 154) inhibition of prolactin secretion and galactorrhoea in a case of pituitary tumour.
    Copinschi G, L'Hermite M, Pasteels JL, Robyn C.
    Gynecol Invest; 1971 Dec 01; 2(1):128-9. PubMed ID: 5170651
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Inhibition of prolactin by an ergot-alkaloid derivative].
    Wenner R, Varga L.
    Gynakol Rundsch; 1973 Dec 01; 13():Suppl 1:64-5. PubMed ID: 4798936
    [No Abstract] [Full Text] [Related]

  • 19. Interference with prolactin release and the maternal behavior of female rats.
    Numan M, Leon M, Moltz H.
    Horm Behav; 1972 Mar 01; 3(1):29-38. PubMed ID: 4680505
    [No Abstract] [Full Text] [Related]

  • 20. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E, Friesen H, Burmeister P.
    Schweiz Med Wochenschr; 1973 Jun 09; 103(23):847-8. PubMed ID: 4351250
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.